Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K was filed by Fresenius Medical Care AG & Co. KGaA, a German partnership limited by shares, for the month of May 2019. The filing, dated May 28, 2019, serves to furnish a press release issued on May 23, 2019, to the U.S. Securities and Exchange Commission.
Financial Metrics
The provided filing text contains only the cover page and signature block of the Form 6-K. It does not include the content of the referenced press release (Exhibit 99.1). Consequently, the filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics.
Material Changes
No material changes versus the prior comparable period are described in the provided text, as the specific financial or operational data required for comparison is absent from this excerpt.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These elements would be contained within the attached press release, which is not included in the input content.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K referencing an external press release dated May 23, 2019.
- Financial performance data and strategic updates are not present in the provided text.
- Investors must locate and review Exhibit 99.1 (the May 23, 2019 Press Release) to obtain actual financial results or material announcements.
- The document is signed by CEO Rice Powell and CFO Michael Brosnan.